Anzeige
❌
Mehr »
Donnerstag, 16.04.2026 - Börsentäglich über 12.000 News
Bohrtreffer, Infrastruktur, Finanzierung: Beginnt hier der Weg zur Produktion?
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: 157088 | ISIN: BG11SOSOBT18 | Ticker-Symbol: 3JR
Frankfurt
16.04.26 | 21:49
1,675 Euro
-0,30 % -0,005
Branche
Pharma
Aktienmarkt
OSTEUROPA
1-Jahres-Chart
SOPHARMA AD Chart 1 Jahr
5-Tage-Chart
SOPHARMA AD 5-Tage-Chart

Aktuelle News zur SOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09:23Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
MiSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141 x3news
DiSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
09.04.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
08.04.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
03.04.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
SOPHARMA Aktie jetzt für 0€ handeln
02.04.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
31.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
30.03.Sopharma AD: Annual financial report4x3news
30.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
27.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20145x3news
26.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
25.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
24.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20143x3news
23.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
20.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
20.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
19.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
18.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
11.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20145x3news
1 2 3 4 5 Weiter >>
107 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1